Product Reports Resources Pricing Login Book a demo
Investor profile

British Patient Capital

Fund Of Funds, Venture Capital · Founded 2018 · Sheffield, United Kingdom

British Patient Capital (BPC) invests in UK venture and growth capital, enabling long-term investment in innovative companies across the UK led by ambitious entrepreneurs

31 portfolio companies Fund Of Funds, Venture Capital · $2.5B invested · 36 investments · Investor rank #1,244 · Last investment 3/2025
Portfolio companies 31 ↑ 3000% 5y
Decacorns 0
Thoroughbreds 3 ↑ 200% 5y
Fund commitments

The funds British Patient Capital backs.

British Patient Capital is a limited partner in 31 funds. 5 of them place in the Power Law Investor Ranking, and the best-ranked are shown here.

Estimated holdings

British Patient Capital’s biggest current holdings.

An estimate of British Patient Capital’s largest live positions — disclosed shareholding × Dealroom’s latest valuation — across 1 companies where British Patient Capital is a named shareholder, worth about $22M in estimated equity value.

#CompanyEst. stakeValuationEst. value
  1. 1 Quell TherapeuticsHealth · Colt 2.39% $936M $22M

Estimated value = British Patient Capital’s disclosed ownership % × Dealroom’s latest company valuation; direct named stakes only, exited positions excluded. Figures are indicative, not reported marks. See the underlying cap tables on Dealroom →

Portfolio analysis

Where British Patient Capital’s portfolio is concentrated.

Distribution of portfolio companies by headquarters country, sector, entry stage and current growth stage. Across all 31 portfolio companies. "Stage entered" is the first priced round the investor joined, derived from the investor’s transaction history.

By countryCount
  1. UK30
  2. Israel1
By sectorCount
  1. Health17
  2. Fintech5
  3. Semiconductors5
  4. Energy2
  5. Enterprise Software2
  6. Security2
  7. Consumer Electronics1
  8. Robotics1
By stage enteredCount
  1. Series B+24
  2. Series A7
By growth stageCount
  1. Late Growth17
  2. Breakout Stage14
Portfolio founders

Where British Patient Capital’s portfolio founders come from.

55 founders across the 31 highest-funded portfolio companies — by current location, university attended, and the companies they worked at before founding. Sourced from the founder records the API links to each portfolio company.

LocationCount
  1. United Kingdom49
  2. Australia2
  3. Austria1
  4. Israel1
  5. United States1
UniversityCount
  1. University of Cambridge8
  2. University of Oxford6
  3. Durham University2
  4. Edinburgh Napier University2
  5. London Business School2
  6. Loughborough University2
  7. University of Bristol2
  8. University of Sheffield2
  9. University of Warwick2
  10. Aston University1
Previous companyCount
  1. Pfizer3
  2. University of Cambridge3
  3. Baseline Consulting2
  4. Microsoft2
  5. NASA2
  6. Peterhouse2
  7. Ablynx1
  8. Accenture1
  9. Aixtron Se1
  10. Alphabet | Google1
Figures on this page are sourced live from the Dealroom next-gen API, joined with Dealroom’s cap-table dataset (estimated holdings) and the Power Law Investor Ranking. News in “Featured in” is drawn from Dealroom’s own coverage — the stories that name this investor, not only those it is the subject of. Market sentiment is omitted until the API exposes it.